BRCA1 and ovarian cancer: In conclusion, the potency of inhibition of the PARP activity induced by ASA-A and ASA-B is notably correlated to their cytostatic effects on UWB1.289, UWB1.289 + BRCA1, OVCAR-3 and SKOV-3 human ovarian cancer cells (Figure 3, Table 4).